Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.

Toward Quality Care in ADHD: Defining the Goals of Treatment

Abstract

Objective: Therapeutic goals for chronic mental disorders like major depressive disorder (MDD) and schizophrenia have evolved in parallel with the growing medical knowledge about the course and treatment of these disorders. Although the knowledge base regarding the clinical course of ADHD, a chronic psychiatric disorder, has evolved beyond symptomatic improvement and short-term treatment response, long-term goals, such as functional remission, have not yet been clearly defined. Method: A PubMed literature search was conducted to investigate the therapeutic goals of pharmacologic treatment referenced in the published literature from January 1998 through February 2010 using the following commonly used ADHD treatments as keywords: amphetamine, methylphenidate, atomoxetine, lisdexamfetamine, guanfacine, and clonidine. This search was then combined with an additional search that included the following outcome keywords: remission, relapse, remit, response, normal, normalization, recovery, and effectiveness. Results: Our search identified 102 publications. The majority (88.2% [90/102]) of these contained predefined criteria for treatment response. Predefined criteria for normalization and remission and/or relapse were presented in 4.9% (5/102), 12.7% (13/102), and 3.9% (4/102) of publications, respectively. There was a lack of consistency between the instruments used to measure outcomes as well as the criteria used to define treatment response, normalization, and remission as well as relapse. Conclusion: The therapeutic goals in treating ADHD should address optimal treatment outcomes that go beyond modest reductions of ADHD symptoms to include syndromatic, symptomatic, and functional remission. Future work should focus on reliable and valid tools to measure these outcomes in the clinical trial setting.

Overview

Integrity signals

Registry

Crossref · 10.1177/1087054712473835

Cites

175 of 175 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 175 references

Research works printed but not linked: 9

  1. Biederman J., 2006, MedGenMed: Medscape General Medicine, 8, 12
  2. Depression Guideline Panel, 1993, Depression in primary care: Volume 1, diagnosis and detection
  3. Greenhill L. L., 2004, Paper presented at the American Psychiatric Association 2004 Annual Meeting
  4. Grizenko N., 2006, Journal of Psychiatry & Neuroscience, 31, 46
  5. Kemner J. E., 2004, Paper presented at the American Psychiatric Association 2004 Annual Meeting
  6. 10.1097/chi.0b013e318054e724 · DOI · Paper page
  7. Steele M., 2005, Paper presented at the American Psychiatric Association 2005 Annual Meeting
  8. Steele M., 2006, Canadian Journal of Clinical Pharmacology, 13, e50
  9. Wilens T. E., 1998, American Journal of Addiction, 7, 156

Cited by

See all 33

Metadata

Authors
Rostain, A., Jensen, P. S., Connor, D. F., Miesle, L. M., & Faraone, S. V.
Affiliations
  • University of Pennsylvania Health System (US)
  • Mayo Clinic (US)
  • University of Connecticut (US)
  • Plymouth City Council (GB)
  • SUNY Upstate Medical University (US)
Venue
Journal of Attention Disorders
Published
2013-02-19
Volume
19
Issue
2
Pages
99-117
ISSN
  • 1087-0547 (ISSN-L)
  • 1557-1246
OpenAlex
W2152960279
Cited by
33
References
175
Citations by year
2025: 1 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 1 · 2020: 5 · 2019: 1 · 2018: 1 · 2017: 4 · 2015: 4 · 2014: 5 · 2013: 1
FWCI
0.45
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Attention Disorders (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Massachusetts General Hospital
  • National Institutes of Health
  • U.S. Food and Drug Administration
  • State University of New York Upstate Medical University
  • National Institute of Mental Health
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
attention deficit hyperactivity disorder, treatment goals, functional remission, relapse, treatment response criteria, outcome measures, stimulant pharmacotherapy, amphetamine, methylphenidate, atomoxetine, lisdexamfetamine, guanfacine, clonidine, chronic mental illness
MeSH terms
Atomoxetine Hydrochloride, Lisdexamfetamine Dimesylate, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Dextroamphetamine, Goals, Humans, Methylphenidate, Propylamines, Quality of Health Care, Guanfacine, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Toward Quality Care in ADHD: Defining the Goals of Treatment. https://app.cochat.ai/papers/10.1177/1087054712473835
The paper
Rostain, A., Jensen, P. S., Connor, D. F., Miesle, L. M., & Faraone, S. V. (2015). Toward Quality Care in ADHD: Defining the Goals of Treatment. Journal of Attention Disorders. https://doi.org/10.1177/1087054712473835

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.